Mitolyn Unveils New “Purple Peel Exploit” to Support Metabolism and Mitochondrial Health COLUMBUS, Ohio, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Mitolyn, an innovative new dietary supplement, is setting the stage for a transformative approach to health with its launch. Engineered to elevate...

IBN Announces Latest Episode of The BioMedWire Podcast featuring Rob Etherington, CEO of Clene Inc. LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce...

Mblue Labs unveils the Anti-aging Powers of Methylene Blue, launches Bluelene HandPlus+ Advanced Age-Repair Treatment Mblue Labs announces the launch of Bluelene HandPlus+, an Advanced Anti-aging Treatment with Methylene Blue - the patented age-reversal ingredient

IBN Announces Latest Episode of The Bell2Bell Podcast featuring Rob Etherington, CEO of Clene Inc. LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce...

Ischemix, Inc. Receives US Department of Defense Funding of $2.9 million to Conduct Phase 1 Study of Drug Candidate to Treat Traumatic Brain Injury (TBI) GRAFTON, Mass., July 07, 2021 (GLOBE NEWSWIRE) -- Ischemix, Inc., a private company focused on developing therapeutics for serious medical conditions, today announced that the US Department of...